[Efficacy of chemotherapy combined with targeted therapy and immunotherapy versus chemotherapy alone in advanced pancreatic cancer:a retrospective cohort study].
Abstract
The triplet regimen of chemotherapy,targeted therapy,and immunotherapy shows potential in improving efficacy and prolonging survival with acceptable safety in patients with advanced pancreatic cancer. However, its definitive benefits require further investigation.
Publication details
- Journal / source
- PubMed
- Volume
- 64
- Issue
- 1
- Pages
- 55–63
- Publication date
- 1 January 2026
- Language
- ZH